Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
CNCR Stock Price Chart Interactive Chart >
CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $14.65 | 52-week high | $19.76 |
| Prev. close | $14.92 | 52-week low | $12.76 |
| Day low | $14.65 | Volume | 100 |
| Day high | $14.87 | Avg. volume | 2,526 |
| 50-day MA | $14.43 | Dividend yield | 0.00001% |
| 200-day MA | $15.16 |
Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio
The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.
CNCR ETF Info
| Issuer | Exchange Traded Concepts |
| Expense Ratio | 0.79% |
| Underlying Index | Loncar Cancer Immunotherapy Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 21.98M |
| Net Asset Value (NAV) | $14.65 |
| Options? | Yes |
| Total Holdings | 31 |
CNCR Top Holdings
| Symbol | Company | % of Total |
| JANX | Janux Therapeutics Inc | 0.06% |
| RAPT | Rapt Therapeutics Inc | 0.05% |
| BGNE | BEIGENE LTD | 0.04% |
| IOVA | Iovance Biotherapeutics Inc | 0.04% |
| IGMS | IGM Biosciences Inc | 0.04% |
| XNCR | Xencor Inc | 0.04% |
| MRUS | Merus NV | 0.04% |
| ALLO | Allogene Therapeutics | 0.04% |
| CRSP | CRISPR Therapeutics AG | 0.04% |
CNCR Price Returns
| 1-mo | 6.70% |
| 3-mo | -0.68% |
| 6-mo | -12.85% |
| 1-year | -24.42% |
| 3-year | -24.55% |
| 5-year | -43.24% |
| YTD | 6.70% |
| 2022 | -42.31% |
| 2021 | -19.24% |
| 2020 | 36.53% |
| 2019 | 24.22% |
| 2018 | -20.65% |
CNCR Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||